ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.590
+0.170 (11.97%)
At close: Oct 8, 2026, 4:00 PM EDT
1.584
-0.006 (-0.38%)
After-hours: Oct 8, 2026, 7:59 PM EDT
ADC Therapeutics Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, ADC Therapeutics stock has a consensus rating of "Buy" and an average price target of $3.33. The average 1-year stock price forecast is 109.43% higher than the current stock price, while the lowest is $2.00 (+25.79%) and the highest is $5.00 (+214.47%).
Price Target: $3.33 (+109.43%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Aug 14, 2026.
Analyst Ratings
The average analyst rating for ADC Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $2 | Hold | Maintains | $2 | +25.79% | Aug 14, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $10 → $5 | Buy | Reiterates | $10 → $5 | +214.47% | Aug 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Jun 8, 2026 |
| Stephens | Stephens | Buy Reiterates $5 | Buy | Reiterates | $5 | +214.47% | Jun 4, 2026 |
Financial Forecast
Revenue This Year
80.55M
from 81.36M
Decreased by -0.99%
Revenue Next Year
100.95M
from 80.55M
Increased by 25.32%
EPS This Year
1.02
EPS Next Year
2.27
from 1.02
Increased by 122.55%
EPS and Forward PE are based on non-GAAP adjusted numbers.